Skip to content

Investor Relations / Publications / Other Publications Referenced in Amarin’s Investor Communications

Other Publications Referenced in Amarin’s Investor Communications

≪ Back to Publications

To search publications using the available search words, please click here:

Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study

Budoff M, Brent Muhlestein J, Le VT, May HT, Roy S, Nelson JR. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study. Clin Cardiol. 2018;1–7.
Free:

https://doi.org/10.1002/clc.22856
EVAPORATE trial
IIT
inflammation
mechanism of action
plaque

Amarin Corporation